Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Orbimed Advisors LLC | 10% Owner | 2023-11-22 | 87,786 | $2.23 | $195.76kSell |
David Henry MacK | President and CEO | 2023-10-18 | 198,407 | $0.53 | $105.16kBuy |
Leila Alland | Chief Medical Officer | 2023-09-15 | 6,291 | $6.62 | $41.65kSell |
Deepika Jalota | Chief Development Officer | 2023-09-15 | 4,104 | $6.62 | $27.17kSell |
David Henry MacK | President and CEO | 2023-08-07 | 85,500 | $0.53 | $45.32kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Orbimed Advisors LLC | 12.81% | 6,589,330 | $10.94M | Insider |
Orbimed Advisors LLC | 12.59% | 6,475,291 | $10.75M | Institution |
Arnold L. Oronsky | 12.58% | 6,469,911 | $10.74M | Insider |
Interwest Partners X LP | 8.75% | 4,502,480 | $7.47M | Insider |
Jpmorgan Chase Co | 7.64% | 3,930,340 | $6.52M | Institution |
Blackrock Inc | 6.28% | 3,229,797 | $5.36M | Institution |
Arrowmark Colorado Holdings LLC | 5.28% | 2,714,143 | $4.51M | Institution |
Euclidean Capital LLC | 5.11% | 2,627,643 | $4.36M | Institution |
V. Oncology Scs Sicavsif Nextech | 4.91% | 2,528,290 | $4.20M | Insider |
Vanguard Group Inc | 4.68% | 2,405,307 | $3.99M | Institution |